Benzinga | Jan 25, 2021 05:14AM EST

Jefferies Upgrades Medifast to Buy, Raises Price Target to $265

Jefferies analyst Stephanie Wissink upgrades Medifast (NYSE:MED) from Hold to Buy and raises the price target from $205 to $265.